Skip to main content
. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065

Fig 3.

Fig 3

Subgroup analyses of progression-free survival. Forest plot shows progression-free survival as assessed by investigator. Hazard ratios are from unstratified analyses. ECOG=Eastern Cooperative Oncology Group; ER=oestrogen receptor; HER2=human epidermal growth factor receptor 2; IHC=immunohistochemistry; PR=progesterone receptor